Target Healthcare REIT (LON:THRL) Hits New 12-Month High – Still a Buy?

Target Healthcare REIT (LON:THRL)’s share price hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as GBX 117 and last traded at GBX 116.40, with a volume of 31,890 shares trading hands. The stock had previously closed at GBX 116.40.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 124 target price on shares of Target Healthcare REIT in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Buy rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of GBX 124.

Target Healthcare REIT Stock Up 0.6%

The firm has a market capitalization of £731.14 million, a price-to-earnings ratio of 8.85, a P/E/G ratio of 1.48 and a beta of 0.71. The stock’s fifty day moving average is GBX 112.59 and its two-hundred day moving average is GBX 108.02.

Target Healthcare REIT (LON:THRL) last announced its quarterly earnings results on Wednesday, September 23rd. The company reported GBX 13.32 EPS for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. As a group, analysts anticipate that Target Healthcare REIT will post 6.22 EPS for the current year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.